when rimonabant will be approved
June 2008
People are asking when rimonabant will be approved.
Not for a few years...and possibly never.
Rimonabant (Acomplia, Zimulti) has been in the news as a promising drug for obesity, smoking cessation, dyslipidemia, and diabetes.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber's Letter includes:
- 12 issues every year, with brief articles about new meds and guidelines
- 48+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive
Already a subscriber? Log in
Volume pricing available. Get a quote